ストックスクリーナーアプリを入手
20.96
0.73%
-0.33
前日終値:
$21.29
開ける：
$21.14
24時間の取引高:
12,851
Relative Volume:
0.02
時価総額：
$1.07B
収益：
$379.81M
当期純損益:
$-21.35M
株価収益率:
-53.16
EPS:
-0.3943
ネットキャッシュフロー:
$35.44M
1週間 パフォーマンス:
+20.29%
1か月 パフォーマンス:
+23.24%
6か月 パフォーマンス:
+45.01%
1年 パフォーマンス:
+18.91%
1日の値動き範囲:
$20.84
$21.18
1週間の範囲:
$20.10
$23.24
52週間の値動き範囲:
$10.96
$23.24
Caredx Inc Stock (CDNA) Company Profile
Compare CDNA vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
20.96 | 1.06B | 379.81M | -21.35M | 35.44M | -0.3943 |
TMO
Thermo Fisher Scientific Inc
|
528.02 | 194.94B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
192.46 | 137.69B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
573.00 | 45.19B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
122.95 | 34.50B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
337.57 | 32.91B | 3.17B | 642.63M | 516.49M | 10.77 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-06 | ダウングレード | Craig Hallum | Buy → Hold |
| 2025-08-26 | 開始されました | William Blair | Mkt Perform |
| 2025-01-15 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | 開始されました | Wells Fargo | Underweight |
| 2024-08-19 | アップグレード | BTIG Research | Neutral → Buy |
| 2024-05-13 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | アップグレード | Craig Hallum | Hold → Buy |
| 2023-11-09 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-03-07 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | ダウングレード | Craig Hallum | Buy → Hold |
| 2023-03-03 | ダウングレード | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | 開始されました | Stephens | Overweight |
| 2021-07-20 | 再開されました | BTIG Research | Buy |
| 2021-06-03 | 開始されました | Goldman | Buy |
| 2021-02-26 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-10-08 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-10-02 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-08-05 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-26 | 開始されました | BTIG Research | Buy |
| 2020-06-19 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-10-01 | 再開されました | Craig Hallum | Buy |
| 2019-05-09 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | 開始されました | Jefferies | Buy |
| 2018-10-23 | 再開されました | Raymond James | Strong Buy |
| 2018-09-18 | 繰り返されました | H.C. Wainwright | Neutral |
| 2017-11-27 | 開始されました | H.C. Wainwright | Buy |
| 2016-06-14 | 繰り返されました | Mizuho | Buy |
| 2015-09-29 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | 開始されました | Craig Hallum | Buy |
| 2015-03-18 | 繰り返されました | Mizuho | Buy |
すべてを表示
Caredx Inc (CDNA) 最新ニュース
CareDx Announces Presentation of More Than 50 Abstracts Including 16 Oral Presentations at the International Society for Heart and Lung Transplantation’s 46th Annual Meeting - BioSpace
Keith Kennedy to Assume Dual Role at CareDx - Medical Product Outsourcing
CareDx Launches AlloSeq Nano for High-Resolution Rapid HLA Typing - TradingView
Insider Sell: CareDx Inc (CDNA) President and CEO Hanna John Wal - GuruFocus
CareDx CEO John Hanna Jr. sells $217,155 in company stock - Investing.com
CareDx (CDNA) CEO sells 10,282 shares at $21.12 under Rule 10b5-1 plan - Stock Titan
CareDx (CDNA) to Sell Lab Products Division to EuroBio Scientifi - GuruFocus
CareDx (CDNA) Launches Innovative AlloSeq Nano Genotyping Soluti - GuruFocus
CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing - BioSpace
CareDx sharpens focus on core testing services - MSN
Assessing CareDx (CDNA) Valuation After Recent Share Price Momentum And Mixed Long Term Returns - Yahoo Finance
CareDx: Watch For Profit-Taking After Recent Positive Preliminary Q1 Results - Seeking Alpha
All You Need to Know About CareDx (CDNA) Rating Upgrade to Buy - Yahoo Finance
Analysts Conflicted on These Healthcare Names: CareDx (CDNA) and Pfizer (PFE) - The Globe and Mail
Are Medical Stocks Lagging CareCloud (CCLD) This Year? - Yahoo! Finance Canada
Sumitomo Mitsui Trust Group Inc. Trims Stake in CareDx, Inc. $CDNA - MarketBeat
CareDx, Inc. (CDNA) Stock Analysis: Exploring Growth Potential And Analyst Consensus - DirectorsTalk Interviews
CareDx Sharpens Focus On Core Testing Services - Sahm
Cathie Wood’s ARK sells CAREDX stock amid ongoing portfolio adjustments By Investing.com - Investing.com Australia
CareDx Inc (CDNA) Shares Surge 27.6% -- What GF Score of 80 Tells Investors - GuruFocus
Cathie Wood’s ARK sells CAREDX stock amid ongoing portfolio adjustments - Investing.com
Proposed CDNA common sales; John Hanna 10b5-1 trades (NASDAQ: CDNA) - Stock Titan
CareDx (CDNA) CEO has 62,049 shares withheld to cover RSU tax bill - Stock Titan
CareDx Up 28%, on Track for Largest Percent Increase Since May 2024 -- Data Talk - 富途牛牛
CareDx Sharpens Focus On Core Testing Services - Benzinga
CareDx (NASDAQ:CDNA) Reaches New 1-Year HighHere's Why - MarketBeat
CareDx Sells Lab Products Business to EuroBio Scientific for $170 Million, Reports 48% Growth in Testing Services Revenue - Minichart
Aehr Test Systems, CareDx, Okta And Other Big Stocks Moving Higher On Thursday - Benzinga
CareDx Divests Lab Products to Refocus on Core Growth - TipRanks
CDNA Reports 17% Increase in Q1 Testing Service Volume - GuruFocus
CareDx (NASDAQ: CDNA) divests Lab Products business in $170M Eurobio deal - Stock Titan
Eurobio scientific signs definitive agreement to acquire CareDx’s transplant Lab Product division - marketscreener.com
CareDx (CDNA) Soars After Divestiture Announcement and Strong Re - GuruFocus
CareDx (CDNA) Sells Lab Products Division for $170M - GuruFocus
CareDx to sell lab products unit for $170 million in cash - Investing.com India
BTIG Maintains CareDx (CDNA) Buy Recommendation - MSN
CareDx Divests Lab Products Business for $170M, Focuses on Precision Medicine Testing - National Today
(CDNA) Volatility Zones as Tactical Triggers - Stock Traders Daily
Caredx announces agreement to divest lab products business to Eurobio Scientific for $170 million and announces first quarter preliminary financial results - marketscreener.com
CareDx (CDNA) Sees 20% Surge Following Q1 Pre-Announcement - GuruFocus
CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial Results - Business Wire
CareDx and Omada Health Compared: Which Medical Stock Stands Out? - National Today
CareDx (CDNA) Q4 Earnings Miss Estimates - Eastern Progress
CareDx to Report First Quarter 2026 Financial Results on April 28, 2026 - BioSpace
How The CareDx (CDNA) Investment Story Is Shifting With New Targets And Policy Risks - Yahoo Finance
CareDx to sell lab products unit for $170 million in cash By Investing.com - Investing.com South Africa
Fenwick Represents CareDX in Divestiture of Lab Products Business to EuroBio Scientific - fenwick.com
Eurobio Scientific Société anonyme entered into a definitive agreement to acquire Caredx AB and Kitted Laboratory Products Business and Related Software of CareDx, Inc. for $170 million. - marketscreener.com
Press Release: CareDx to Report First Quarter 2026 Financial Results on April 28, 2026 - 富途牛牛
Aug PreEarnings: Whats the RSI of CareDx Inc stockMarket Trend Summary & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Book value per share of CareDx, Inc. – DUS:1K9 - TradingView — Track All Markets
Caredx Inc (CDNA) 財務データ
収益
当期純利益
現金流量
EPS
0.26%
0.02%
大文字化:
|
ボリューム (24 時間):